Results 271 to 280 of about 156,767 (359)

Preoperative co-application of bevacizumab and tissue plasminogen activator in vitrectomy for proliferative diabetic retinopathy. [PDF]

Arq Bras Oftalmol
Aras C, Senturk F, Erdur SK, Kocabora MS, Dogramaci M, Burke C, Aras E.   +6 more
europepmc   +1 more source

-315-CORONARY THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN ACTIVATOR (TPA) IN EXPERIMENTAL MODEL

, 1986
Katsuo Kanmatsuse, Nagao Kajiwara, Y Satoh, Hiromi Seto, Masayuki lwasaki, Tomiya Ohba, Kohji Yumi, lkuyoshi Watanabe   +7 more
openalex   +2 more sources

Massive Acute Thrombosis of a Mechanical Mitral Valve in a Young Patient on Acenocoumarin: A Case Report Comparing Surgical and Thrombolytic Approaches

Clinical Case Reports, Volume 13, Issue 6, June 2025.
ABSTRACT Obstructive mechanical mitral valve thrombosis is a life‐threatening emergency requiring urgent intervention. Surgery is often first‐line; thrombolysis may be considered in high‐risk cases. A multidisciplinary approach is essential to balance thromboembolic and bleeding risks, emphasizing early recognition, optimized anticoagulation, and ...
Said Khallikane, Bassam Bencharfa, Noureddine Atmani, Abdessamad Abdou, Ayoub Belhadj, Younes Aissaoui   +5 more
wiley   +1 more source

A case of image-guided hematometrocolpos drainage requiring tissue plasminogen activator in a pediatric patient. [PDF]

J Surg Case Rep
Sharma P, Shah J, Sokkary N.
europepmc   +1 more source

The activated protein C-mediated enhancement of tissue-type plasminogen activator-induced fibrinolysis in a cell-free system.

, 1990
Laszlo Bajzar, James C. Fredenburgh, Michael E. Nesheim   +2 more
openalex   +1 more source

Contemporary Perspectives on Chronic Renal Disorders

Chronic Diseases and Translational Medicine, Volume 11, Issue 2, Page 89-104, June 2025.
ABSTRACT The prevalence of renal diseases and its associated burden on healthcare have tremendously risen in the past few years. From simple markers assessing kidney function, current renal research delves into understanding the diseases at the cellular and molecular levels and not just at treating, but at improving quality of life, arresting ...
Deenadhayalan Ashok, Poornima Ajay Manjrekar, Bhushan C. Shetty, Sujina S. S, Rukmini Mysore Srikantiah, Sowndarya Kollampare   +5 more
wiley   +1 more source

The reperfusion rates after recombinant human tissue plasminogen activator thrombolysis depend not on a few but on a plethora of influencing factors. [PDF]

Rev Assoc Med Bras (1992)
Finsterer J, Scorza FA, Scorza CA.
europepmc   +1 more source

Tissu-type Plasminogen Activator

Japanese Journal of Thrombosis and Hemostasis, 1990
openaire   +2 more sources

C1 inhibitor deficient hereditary angioedema is related to endothelial dysfunction in young adult and middle‐aged patients

Clinical and Translational Allergy, Volume 15, Issue 6, June 2025.
Abstract Background Hereditary angioedema (HAE) is a rare, autosomal dominantly inherited disease characterised by mucocutaneous oedema attacks. Vasoactive mediators and the endothelium play an important role in the pathogenesis of HAE. We aimed to evaluate the endothelial dysfunction in HAE. Methods The study included 35 C1 inhibitor deficient (C1‐INH)
Gokce Gul Atay Sensoy, Derya Baykız, İlkim Deniz Toprak, Deniz Eyice Karabacak, Erdem Bektas, Derya Unal, Aslı Gelincik, Semra Demir   +7 more
wiley   +1 more source

Tissue-plasminogen activator effects on the phenotype of splenic myeloid cells in acute inflammation. [PDF]

J Inflamm (Lond)
Seillier C, Lesec L, Hélie P, Marie C, Vivien D, Docagne F, Le Mauff B, Toutirais O.   +7 more
europepmc   +1 more source